5351 - 5375 of 7916 Results
Title
Year
-
OPENTitle: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2Journal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 44Issue #: 6Start Page: 1446End Page: 1459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4Best OA location URL: https://europepmc.org/articles/pmc6450775?pdf=renderCitation Count: 8
-
RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 9
-
OPENTitle: Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0282-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-018-0282-4Citation Count: 185
- Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial2018OPENTitle: Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 60Issue #:Start Page: 51End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.10.005Best OA location URL: http://manuscript.elsevier.com/S1353802018304310/pdf/S1353802018304310.pdfCitation Count: 16
-
OPENTitle: Abstracts from the 50th European Society of Human Genetics Conference: PostersJournal Name: European Journal of Human GeneticsPublisher: Springer Science and Business Media LLCVol: 26Issue #: S1Start Page: 113End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41431-018-0247-7Best OA location URL: https://www.nature.com/articles/s41431-018-0247-7.pdfCitation Count: 4
-
OPENTitle: Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson’s disease patients OFF and ON medicationsJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 119Issue #:Start Page: 24End Page: 33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2018.07.024Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2018.07.024Citation Count: 15
-
OPENTitle: Importance of low diagnostic Accuracy for early Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1551End Page: 1554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27485Best OA location URL: https://europepmc.org/articles/pmc6544441?pdf=renderCitation Count: 84
-
RESTRICTEDTitle: Meta-analysis of amantadine efficacy for improving preclinical research reliabilityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1555End Page: 1557Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27486Citation Count: 7
-
RESTRICTEDTitle: Modeling Parkinson’s disease and treatment complications in rodents: Potentials and pitfalls of the current optionsJournal Name: Behavioural Brain ResearchPublisher: Elsevier BVVol: 352Issue #:Start Page: 142End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbr.2017.12.014Citation Count: 20
-
RESTRICTEDTitle: Sleep disorders and Parkinson disease; lessons from geneticsJournal Name: Sleep Medicine ReviewsPublisher: Elsevier BVVol: 41Issue #:Start Page: 101End Page: 112Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smrv.2018.01.006Best OA location URL: http://escholarship.mcgill.ca/downloads/tb09j975fCitation Count: 33
-
OPENTitle: The Parkinson's disease gene product DJ-1 modulates miR-221 to promote neuronal survival against oxidative stressJournal Name: Redox BiologyPublisher: Elsevier BVVol: 19Issue #:Start Page: 62End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2018.07.021Best OA location URL: https://doi.org/10.1016/j.redox.2018.07.021Citation Count: 74
-
RESTRICTEDTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://europepmc.org/articles/pmc7234797?pdf=renderCitation Count: 24
-
OPENTitle: Modulation of intracellular calcium signaling by microRNA-34a-5pJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1050-7Best OA location URL: https://www.nature.com/articles/s41419-018-1050-7.pdfCitation Count: 28
-
OPENTitle: Regional vesicular acetylcholine transporter distribution in human brain: A [18F]fluoroethoxybenzovesamicol positron emission tomography studyJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 526Issue #: 17Start Page: 2884End Page: 2897Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.24541Best OA location URL: http://deepblue.lib.umich.edu/bitstream/2027.42/146604/1/cne24541.pdfCitation Count: 48
-
RESTRICTEDTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Citation Count: 31
-
RESTRICTEDTitle: Animal models of neurodegenerative diseasesJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 21Issue #: 10Start Page: 1370End Page: 1379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41593-018-0236-8Best OA location URL: https://europepmc.org/articles/pmc6615039?pdf=renderCitation Count: 374
-
OPENTitle: CSF Aβ1–42 level is associated with cognitive decline in early Parkinson’s disease with rapid eye movement sleep behavior disorderJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-018-0129-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-018-0129-5Citation Count: 11
-
OPENTitle: USP 14 inhibition corrects an in vivo model of impaired mitophagyJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 10Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.201809014Best OA location URL: https://doi.org/10.15252/emmm.201809014Citation Count: 82
-
OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd181434?id=journal-of-parkinsons-disease%2Fjpd181434Citation Count: 21
- Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat2018OPENTitle: Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the ratJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-018-0066-0Best OA location URL: https://www.nature.com/articles/s41531-018-0066-0.pdfCitation Count: 48
-
OPENTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: Hindawi LimitedVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Best OA location URL: https://doi.org/10.1111/ane.13028Citation Count: 36
-
OPENTitle: Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/pmic.201800108Best OA location URL: https://europepmc.org/articles/pmc6283072?pdf=renderCitation Count: 57
-
OPENTitle: Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson’s disease patientsJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-31988-0Best OA location URL: https://www.nature.com/articles/s41598-018-31988-0.pdfCitation Count: 21
-
OPENTitle: Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 320Issue #: 11Start Page: 1151End Page: 1151Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2018.12917Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2702872/jama_ossenkoppele_2018_pc_180007.pdfCitation Count: 324
-
OPENTitle: β2‐adrenoreceptor medications and risk of Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 84Issue #: 5Start Page: 683End Page: 693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25341Best OA location URL: https://europepmc.org/articles/pmc6881195?pdf=renderCitation Count: 65